|
End-of-day quote
Other stock markets
|
||
| - | - |
|
| 06-30 | Jerusalem Pharmaceuticals Announces Board Changes | CI |
| 05-14 | Jerusalem Pharmaceuticals Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 135M 135M 119M 111M 102M 190M 12.93B 195M 1.31B 513M 6.4B 507M 496M 22.12B | P/E 2024 |
13.7x | P/E 2025 | 8.13x |
|---|---|---|---|---|---|
| Enterprise Value | 124M 124M 109M 102M 93.42M 175M 11.89B 179M 1.21B 472M 5.88B 466M 456M 20.33B | EV / Sales 2024 |
1.47x | EV / Sales 2025 | 1.47x |
| Free-Float |
35.74% | Yield 2024 |
2.09% | Yield 2025 | 3.26% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2013-06-30 | |
Mohammed Natour
DFI | Director of Finance/CFO | - | 2020-02-29 |
Lina Masrouji
CTO | Chief Tech/Sci/R&D Officer | - | 1988-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 91 | - | |
Nidal Kamal
BRD | Director/Board Member | - | - |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.67% | +1.43% | +16.90% | +74.77% | 49.64B | ||
| -2.09% | +3.84% | +64.12% | +113.57% | 36.54B | ||
| +2.06% | +2.92% | -6.22% | +25.17% | 12.22B | ||
| +2.14% | -1.78% | +14.55% | +75.28% | 11.48B | ||
| +0.19% | +1.35% | +31.58% | +132.30% | 9.04B | ||
| -2.63% | +3.94% | +50.54% | -4.41% | 6.94B | ||
| +0.17% | -0.68% | +11.96% | +33.49% | 6.74B | ||
| +3.53% | +0.87% | +5.47% | +183.15% | 6.45B | ||
| +0.61% | -6.24% | -32.70% | -1.66% | 5.42B | ||
| Average | +1.50% | -0.77% | +17.36% | +70.19% | 16.05B | |
| Weighted average by Cap. | +1.19% | +0.44% | +26.64% | +80.28% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 39.82M 39.82M 34.99M 32.66M 29.97M 56.11M 3.81B 57.49M 387M 151M 1.89B 150M 146M 6.52B | 48.95M 48.95M 43.01M 40.14M 36.84M 68.97M 4.69B 70.67M 476M 186M 2.32B 184M 180M 8.02B |
| Net income | 5.04M 5.04M 4.43M 4.13M 3.79M 7.1M 483M 7.27M 49M 19.16M 239M 18.91M 18.5M 825M | 10.18M 10.18M 8.95M 8.35M 7.67M 14.35M 975M 14.7M 99.04M 38.73M 483M 38.23M 37.4M 1.67B |
| Net Debt | -10.32M -10.32M -9.07M -8.47M -7.77M -14.54M -989M -14.9M -100M -39.26M -489M -38.75M -37.91M -1.69B | -10.9M -10.9M -9.57M -8.94M -8.2M -15.35M -1.04B -15.73M -106M -41.45M -516M -40.91M -40.02M -1.79B |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
















